Expanding live donor kidney transplantation through advocacy training and social media
通过宣传培训和社交媒体扩大活体肾移植
基本信息
- 批准号:9912138
- 负责人:
- 金额:$ 62.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdultAdvocacyAfrican AmericanAmericanAwarenessCaringCaucasiansCessation of lifeCharacteristicsChronicClinicalCollaborationsCommunicationCommunitiesCountryDataDevelopmentDonor personEducationEffectivenessEnd stage renal failureEnrollmentEthnic OriginEvaluationEventFacebookFamily memberFocus GroupsFriendsFutureGroup InterviewsHeterogeneityHispanic AmericansHispanicsIncidenceIndividualInterventionKidneyKidney TransplantationKnowledgeLeadershipLinkMidwestern United StatesOrganOutcomeParticipantPatientsPersonsPilot ProjectsPopulationPopulation HeterogeneityProtocols documentationRaceRandomizedRandomized Controlled TrialsResourcesRiskSocial NetworkSocietiesSubgroupSurvival AnalysisTestingTimeTrainingTraining ProgramsTransplant SurgeonTransplantationUnited Network for Organ SharingUnited StatesViralWaiting Listsarmclinical carecomparative effectivenessdesignmembernovelpatient populationprimary outcomeprogramsprospectivepublic health relevancesocial mediastandard of caretransplant centerstreatment effecttrial comparing
项目摘要
Summary
Over 90,000 individuals in the United States await kidney transplantation. Only about 12,000 will receive a
deceased donor transplant each year, and recent efforts to increase deceased donation have been largely
unsuccessful. As a result, most candidates on the waiting list have a higher chance of dying than of being
offered a deceased donor kidney. Live donor kidney transplantation (LDKT) eliminates the wait and offers
superior survival, but accounts for fewer than 6,000 additional transplants per year despite a huge potential
pool of millions of adults living in the US. Worse, LDKT rates are lowest among Hispanic and African American
candidates who account for over 30% of the waitlist. Regardless of race, known barriers to identifying a live
donor include lack of education, reluctance to discuss one's illness, and hesitance to ask others to donate.
We have developed two novel interventions to address these barriers. The first is a 6-month training program
that combines education, advocacy, and instrumental support by pairing candidates with a live donor champion
(LDC): a friend, family member, or community member trained to spread awareness of ESRD, LDKT, and the
candidate's story throughout their social network. The second is a less-intensive Facebook (FB) app (designed
in collaboration with FB leadership) that leverages the broad reach of social media to spread awareness,
facilitating FB posts about the candidate's story, providing links to education about ESRD and LDKT, and
documenting the candidate's search for a donor through a "chronically viral" Facebook story.
In pilot studies at our center, participants of both interventions were significantly more likely to undergo LDKT
compared to matched controls. While encouraging, pilot testing has been non-randomized and limited to our
center and its unique patient population. Furthermore, it remains unclear how intense an intervention is
necessary, i.e. the less-intense FB approach or the more-intense champion approach. To assess the real-
world effectiveness of the LDC program and/or the Facebook app in expanding live donation among a
heterogeneous population of waitlist candidates, we now propose to test these interventions at three busy
transplant centers that serve a heterogeneous group of largely underserved patients.
The relative dearth of deceased donors has caused a profound organ shortage; it is essential to turn to novel
efforts that increase live donation. Development and widespread implementation of culturally competent LDC
and Facebook App interventions has the potential to increase the overall incidence of LDKT while also
addressing disparities in access to LDKT.
总结
在美国,超过90,000人等待肾移植。只有大约12,000人将获得
每年都有死者捐赠者移植,最近增加死者捐赠的努力在很大程度上是
不成功。因此,等待名单上的大多数候选人死亡的可能性高于被
提供了一个已故捐赠者的肾脏活体供肾移植(LDKT)消除了等待,
上级存活率,但尽管有巨大的潜力,但每年的额外移植不到6,000例
数以百万计的成年人生活在美国。更糟糕的是,拉美裔和非洲裔美国人的LDKT率最低
占候补名单30%以上的候选人。无论种族如何,识别活体的已知障碍
捐赠者包括缺乏教育,不愿谈论自己的疾病,以及不愿要求别人捐赠。
我们开发了两种新的干预措施来解决这些障碍。首先是为期6个月的培训计划
通过将候选人与现场捐赠者冠军配对,
(LDC):朋友、家庭成员或社区成员,接受过传播ESRD、LDKT和
候选人的故事在他们的社交网络上。第二个是一个不太密集的Facebook(FB)应用程序(设计
与FB领导层合作),利用社交媒体的广泛影响力来传播意识,
促进FB关于候选人故事的帖子,提供ESRD和LDKT教育的链接,以及
通过一个“慢性病毒式”的Facebook故事记录候选人寻找捐赠者的过程。
在我们中心的试点研究中,两种干预措施的参与者更有可能接受LDKT
与对照组相比。虽然令人鼓舞,但试点测试是非随机的,仅限于我们的
中心及其独特的患者群体。此外,目前还不清楚干预的力度有多大
必要的,即不太激烈的FB方法或更激烈的冠军方法。去评估真实的-
最不发达国家计划和/或Facebook应用程序在扩大世界各地的现场捐赠的有效性,
由于等待名单候选人的异质人口,我们现在建议在三个忙碌的地方测试这些干预措施。
这些移植中心服务于一组异质性的、服务不足的患者。
已故捐赠者的相对缺乏造成了严重的器官短缺;转向新的器官是至关重要的。
努力增加活体捐赠。发展和广泛实施文化能力最不发达国家
和Facebook App干预有可能增加LDKT的总体发病率,
解决在获得最不发达国家培训中心方面的差距。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW M. CAMERON其他文献
ANDREW M. CAMERON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW M. CAMERON', 18)}}的其他基金
Development of an Interactive Bioethics Training Module for Healthcare Providers Treating Patients Who Need Liver Transplant for Alcohol-associated Liver Disease
为治疗酒精相关性肝病需要肝移植的患者的医疗保健提供者开发交互式生物伦理学培训模块
- 批准号:
10785093 - 财政年份:2023
- 资助金额:
$ 62.73万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10560540 - 财政年份:2019
- 资助金额:
$ 62.73万 - 项目类别:
Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis
项目1-严重酒精性肝炎早期肝移植患者的队列和伦理分析
- 批准号:
10356013 - 财政年份:2019
- 资助金额:
$ 62.73万 - 项目类别:
Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis
项目1-严重酒精性肝炎早期肝移植患者的队列和伦理分析
- 批准号:
10560558 - 财政年份:2019
- 资助金额:
$ 62.73万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10356010 - 财政年份:2019
- 资助金额:
$ 62.73万 - 项目类别:
Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation
多学科方法对接受肝移植的重症酒精性肝炎患者进行研究
- 批准号:
10093975 - 财政年份:2019
- 资助金额:
$ 62.73万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 62.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 62.73万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 62.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 62.73万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 62.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 62.73万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 62.73万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 62.73万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 62.73万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 62.73万 - 项目类别:
Standard Grant